02-04-2021 02:17 PM | Source: Religare Broking Ltd
Dabur India Ltd - Stellar performance, ayurvedic and health portfolio to drive growth By Religare Broking
Dabur India Ltd.
Outlook & Valuation
Dabur’s portfolio is gaining traction each passing quarter largely driven by its focus on health and hygiene segment, new product launches, heavy investment behind their power brands and expanding in rural area. In addition cost optimisation measures and improving go-to-market approach is well supporting company’s growth. We remain positive on the company’s long term growth plans and have maintained a Buy on the stock with a target price of Rs 616.
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer http://ex.religareonline.com/disclaimer
SEBI Registration number is INZ000174330
Above views are of the author and not of the website kindly read disclaimer
Latest News
Commodity Research Evening Track by Kotak Securities
Quote on Nifty by Rupak De, Senior Technical Analyst...
FIIs stood as net buyers in equities as per November...
Quote on Rupee by Jateen Trivedi, VP Research Analys...
Market Quote : State Election Results Boost Market S...
Daily Market Analysis : Markets began the week on a ...
Daily Market Commentary : Nifty50 Gaps Up, Rises 315...
Inflation to ease, economic growth to accelerate in ...
Demand for entry-level talent surges 59 pc in India`...
Sensex closes up by 992 points, Adani Ports, L&T top...